Precision BioPharma
Precision BioPharma is a drug development organization focused on rapid development of small-molecule therapeutics using an adaptive translational research approach and AI/ML-assisted research processes. The organization emphasizes medicinal chemistry, preclinical pipeline development (antiviral, anti-inflammatory, anti-thrombotic candidates), formulation development and clinical trial strategy including regulatory and IND pathways.
Industries
Nr. of Employees
small (1-50)
Precision BioPharma
Products
Small-molecule candidate for COVID-19 (PB-004)
A small-molecule compound in development described as having potential utility in treating COVID-19.
Repurposed therapeutic planned for Phase 2B (PB-200)
An FDA-approved drug repurposed and planned for Phase 2B trials to address COVID-19-induced pneumonia.
Small-molecule candidate for COVID-19 (PB-004)
A small-molecule compound in development described as having potential utility in treating COVID-19.
Repurposed therapeutic planned for Phase 2B (PB-200)
An FDA-approved drug repurposed and planned for Phase 2B trials to address COVID-19-induced pneumonia.
Services
Small-molecule discovery and progression through preclinical candidate identification using medicinal chemistry and AI-assisted workflows.
Design and planning support for clinical trials including strategy for Phase II studies.
Regulatory strategy services to support IND submissions and interactions with global regulatory authorities.
Development of novel formulations and assessment of approved drugs for repurposing in new indications.
Small-molecule discovery and progression through preclinical candidate identification using medicinal chemistry and AI-assisted workflows.
Design and planning support for clinical trials including strategy for Phase II studies.
Regulatory strategy services to support IND submissions and interactions with global regulatory authorities.
Development of novel formulations and assessment of approved drugs for repurposing in new indications.
Expertise Areas
- Clinical trial management and strategy
- Medicinal chemistry and lead optimization
- Preclinical drug development
- Regulatory strategy and IND submissions
Key Technologies
- Adaptive translational research
- Machine learning / AI for research
- Medicinal chemistry
- Drug repurposing methodologies
News & Updates
Blog post describing company approach and mission elements.
Introductory blog post on drug discovery challenges and screening assays.
Blog post describing company approach and mission elements.
Introductory blog post on drug discovery challenges and screening assays.